Cefpodoxime Proxetil



Cefpodoxime Proxetil





(sef poe docks’ eem)

PREGNANCY CATEGORY B


Drug Classes

Antibiotic

Cephalosporin (third generation)


Therapeutic Actions

Bactericidal: Inhibits synthesis of bacterial cell wall, causing cell death.


Indications



  • Lower respiratory infections, including community-acquired pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae


  • URIs, including acute maxillary sinusitis, caused by Streptococcus pyogenes, H. influenzae, Moraxella catharrhalis


  • Uncomplicated skin and skin structure infections caused by Staphylococcus aureus, S. pyogenes


  • UTIs caused by Escherichia coli, Proteus mirabilis, Klebsiella, Staphylococcus saprophyticus


  • Otitis media caused by S. pneumoniae, H. influenzae, M. catarrhalis


  • STD caused by Neisseria gonorrhoeae



Available Forms

Tablets—100, 200 mg; oral suspension—50 mg/5 mL, 100 mg/5 mL



Dosages

Adults

100–400 mg every 12 hr PO depending on severity of infection; continue for 5–14 days.

Pediatric patients

5 mg/kg per dose PO every 12 hr; do not exceed 100–200 mg per dose; continue for 10 days.

Jul 20, 2016 | Posted by in NURSING | Comments Off on Cefpodoxime Proxetil

Full access? Get Clinical Tree

Get Clinical Tree app for offline access